EXTH-43. TARGETING THE DNA DAMAGE RESPONSE THROUGH COMBINATION MDM2 AND AKT INHIBITOR THERAPY IMPROVES TEMOZOLOMIDE EFFECTIVENESS IN CHEMO-RESISTANT GLIOBLASTOMA

Authors: Jenna Koenig, Barbara Bailey, Anthony Alfonso, M Reza Saadatzadeh, Khadijeh Bijangi-Vishehsaraei, Pankita Pandya, Nur Damayanti, Erika Dobrota, Courtney Young, Harlan Shannon, Karen Pollok

Published: 2023-11-11

DOI: 10.1093/neuonc/noad179.0896

Source: Full article

EXTH-43. TARGETING THE DNA DAMAGE RESPONSE THROUGH COMBINATION MDM2 AND AKT INHIBITOR THERAPY IMPROVES TEMOZOLOMIDE EFFECTIVENESS IN CHEMO-RESISTANT GLIOBLASTOMA

Abstract